Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

EMERALD NATIONAL LABORATORY LLC

NPI: 1215594270 · CORVALLIS, OR 97333 · Clinical Medical Laboratory · NPI assigned 05/24/2019

$10.15M
Total Medicaid Paid
211,072
Total Claims
93,289
Beneficiaries
15
Codes Billed
2020-06
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMASTEN, ADAM (PARTNER)
NPI Enumeration Date05/24/2019

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 3,757 $28K
2021 15,829 $443K
2022 46,898 $1.94M
2023 60,640 $3.01M
2024 83,948 $4.73M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 101,611 45,721 $6.20M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 101,549 45,223 $3.91M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,400 689 $30K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,394 689 $10K
80320 287 89 $0.00
80359 287 89 $0.00
80345 287 89 $0.00
80353 287 89 $0.00
80358 287 89 $0.00
80324 287 89 $0.00
80349 287 89 $0.00
80346 287 89 $0.00
80361 288 89 $0.00
80365 247 77 $0.00
80348 287 89 $0.00